Loading clinical trials...
Loading clinical trials...
Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Conditions
Locations
79
Spain
Centro de Salud Águilas Sur
Aguilas (Murcia), Spain
Consultorio Médico de Albelda
Albelda (Huesca), Spain
Centro de Salud Alcantarilla-Sangonera
Alcantarilla (Murcia), Spain
Centro de Salud Alquerías Raal
Alquerías (Murcia), Spain
Centro de Salud Aranda Norte
Aranda de Duero (Burgos), Spain
Centro de Salud Ávila Estación
Ávila, Spain
Start Date
April 26, 2017
Primary Completion Date
September 18, 2018
Completion Date
September 18, 2018
Last Updated
September 30, 2019
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions